Insider Insights
24.03.2022
Manufacturer paybacks of E1 billion in relation to

Consequently, paybacks from pharmaceutical manufacturers of around €1 billion will be due from pha...

Read more
News
23.03.2022
PMA Insights: Week 12

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Insider Insights
21.03.2022
Revise payment percentage paid

The DHSC is proposing to increase the statutory scheme payment percentage for 2022 from 10.9% to 14....

Read more
Insider Insights
17.03.2022
Germany: Proposed new pharmaceutical cost

The proposals are set out in the draft Statutory Health Insurance Financial Stabilisation Bill which...

Read more
Articles
10.03.2022
Orphan status higher prices in the UK

Beyond the regulatory level, a well-recognised challenge for companies launching drugs in orphan dis...

Read more
Insider Insights
01.03.2022
Spotlight on access to orphan drugs

The Ministry of Health hhas published a report on the “evolution of funding and fixing of the pric...

Read more
Insider Insights
24.02.2022
Legislation-extends-CPR-and-CTS-membership

The National Recovery and Resilience Plan had extended the membership to the CPR and CTS until 28th...

Read more
Insider Insights
21.02.2022
Eligibility for prescribing testosterone

The change is intended to simplify care pathways and the management of patients requiring testoster...

Read more
Insider Insights
18.02.2022
Pharmacy chains reduce price of contraceptive pill

Superdrug has reduced the price of a generic version of the emergency hormonal contraceptive pill (l...

Read more
Insider Insights
14.02.2022
Fall in wholesale margins on prescription drugs

Wholesale margins on prescription drugs fell to 3.99% in 2021 (down from 4.09% in the previous year)...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.